SHORT-TERM OUTCOMES OF LAPAROSCOPIC GASTRECTOMY FOR STAGE II-III GASTRIC CANCER AT CANTHO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL FROM 2022 TO 2025

Van Hien Nguyen1, Thien Tri Tran1, , Van Tuan Nguyen1, Van Doi Mai1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Gastric cancer currently represents not only an economic burden but also a significant social burden in Vietnam as well as worldwide. It is one of the most common gastrointestinal malignancies; alongside colorectal and esophageal cancers, gastric cancer ranks fifth in incidence (9%-16,277 cases) among all newly diagnosed cancers in Vietnam in 2022. At Can Tho University of Medicine and Pharmacy Hospital, laparoscopic surgery for gastric cancer has been implemented since the early days of its establishment. However, there has been no well-defined study evaluating the effectiveness of this approach, particularly in patients with stage II-III disease. Objective: To evaluate the short-term outcomes of laparoscopic gastrectomy for stage II-III gastric cancer at Can Tho University of Medicine and Pharmacy Hospital. Materials and methods: This was a prospective case series of 33 patients diagnosed with stage II-III gastric cancer at Can Tho 

University of Medicine and Pharmacy Hospital who underwent laparoscopic surgery between January 2022 and April 2025. Results: The male-to-female ratio was 27/6. The mean age was 64.09 ± 13.24 years. The most common tumor location was the pylorus (30.3%). The mean operative time was 265.55 minutes. The mean number of retrieved lymph nodes was 11.45. The mean length of hospital stay was 14.1 days. Postoperatively, there were 2 cases of early bowel obstruction, 1 case of anastomotic leak, and 1 case of anastomotic stenosis. Conclusion: Laparoscopic gastrectomy for stage II-III gastric cancer is a safe and effective approach, with favorable postoperative recovery. 

Article Details

References

1 Bray F., Laversanne M., Sung H., Ferlay J., Siegel R. L., Soerjomataram I., et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. 74(3), 229-263. https://doi.org/10.3322/caac.21834.
2 Han D., Zhang Z., Deng J. & Du H. Survival analysis of gastric malignancy patients: identifying key prognostic factors. Transl Cancer Res. 2025. 14(3), 1928-1941. https://doi.org/10.21037/tcr-24-1285.
3 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2025 (7th edition). Gastric Cancer. 2026. 29(2), 271-299. https://doi.org/10.1007/s10120-025-01698-4.
4 Kesgin Y. M., Bulut S., Atar B., Sürek A., Dönmez T., Gümüşoğlu A. Y., et al. Comparison of textbook outcomes between laparoscopic and open total gastrectomy for gastric cancer. BMC Surg. 2025. 25(1), 169. https://doi.org/10.1186/s12893-025-02891-z.
5 Etoh T., Ohyama T., Sakuramoto S., Tsuji T., Lee S. W., Yoshida K., et al. Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer: The JLSSG0901 Randomized Clinical Trial. JAMA Surg. 2023. 158(5), 445-454. https://doi.org/10.1001/jamasurg.2023.0096.
6 Yu J., Huang C., Sun Y., Su X., Cao H., Hu J., et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. Jama. 2019. 321(20), 1983-1992. https://doi.org/10.1001/jama.2019.5359.
7 Nguyễn Vũ Tuấn Anh. Kết quả phẫu thuật nội soi cắt gần toàn bộ dạ dày điều trị ung thư dạ dày. Luận án Tiến sĩ Y học, Đại học Y dược Thành phố Hồ Chí Minh. 2023.
8 Mranda Geofrey Mahiki, Xue Ying, Zhou Xing-Guo, Yu Wang, Wei Tian, Xiang Zhi-Ping, et al. Revisiting the 8th AJCC system for gastric cancer: A review on validations, nomograms, lymph nodes impact, and proposed modifications. Annals of Medicine and Surgery. 2022. 75, 103411. https://doi.org/10.1016/j.amsu.2022.103411.
9 Dat Tran Quang, Thong Dang Quang, Nguyen Doan Thuy, Hai Nguyen Viet, Phuoc Tran Duy, Anh Nguyen Vu Tuan, et al. Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer: The UMC-UPPERGI-01 Randomized Clinical Trial. JAMA Surgery. 2026. 161(1), 9-18. https://doi.org/10.1001/jamasurg.2025.4929.
10 Nguyễn Thanh Quân, Nguyễn Văn Lâm, Nguyễn Thị Hồng Nga. Đánh giá kết quả sớm điều trị ung thư dạ dày giai đoạn III kèm nạo vét hạch D2 bằng phẫu thuật nội soi tại Bệnh viện Đa khoa Trung ương Cần Thơ và Bệnh viện Trường Đại học Y Dược Cần Thơ. Tạp chí Y Dược học Cần Thơ. 2022. (46), 91-98.
11 Nguyễn Văn Thanh. Kết quả sớm phẫu thuật nội soi cắt toàn bộ dạ dày trong điều trị ung thư thân vị tại Bệnh viện Chợ Rẫy. Tạp chí Y Dược học Cần Thơ. 2025. (89), 309-315. https://doi.org/10.58490/ctump.2025i89.3479.